SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, announced that it will participate in several prominent investor conferences throughout September 2025. SBC Medical will deliver large presentations and conduct one-on-one meetings with institutional investors. Below is a summary of the Company’s participation in investor conferences: H.C. Wainwright Conf...

MSCI Inc. (NYSE: MSCI) launched a Private Credit Factor Model to help investors overcome the lack of transparency in the asset class and better assess the long-term risks it presents in their overall portfolios. As investors continue to increase their allocations to the private credit market, they face a critical challenge: A lack of data and insights into their investments can obscure their view of risks of private investments within the context of their total portfolio. Over the past deca...

Nearly nine in ten organizations have experienced an increase in network outages over the past two years, with more than a quarter reporting increases of 25% to 50%, according to new research from Opengear, a Digi International company (NASDAQ, DGII, (www.digi.com). The rise in outages has cost more than a third of businesses between $1m and $5m in the past year alone. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250903508317/en/N...

RevolKa Ltd. (RevolKa), a venture-backed biotech company providing a cutting-edge AI-driven protein engineering technology platform, called aiProtein® is pleased to announce the launch of a new contract research service, 'RevoAb™'. This service engineers antibodies to improve physicochemical properties while protecting antigen binding affinity. About RevoAb™ Since December 2023, RevolKa has offered contract research services for antibody engineering using aiProtein®, its AI-driven protein eng...

Agreena, the company powering the global transition to regenerative agriculture, has achieved verification of its AgreenaCarbon Project under Verra’s Verified Carbon Standard (VCS) Program’s VM0042 Improved Agricultural Land Management v2.0 methodology – the first large-scale arable agriculture project to do so. By passing this milestone, Agreena is now issuing 2.3 million Verra-verified carbon credits that are not only readily available, but deliver immediate, measurable climate impact. This...